Genetic Engineering News reveals the top 10, for investor information:
1. Pfizer. (no Figure)
2. Johnson and Johnson (JNJ:NYSE, $171.53 bn)
3. GlaxoSmithKline (GSK:NYSE, $149.61 bn)
4. Sanofi Aventis (SNY:NYSE, $114.53 bn)
5. Novartis (NVS:NYSE, $111.37 bn)
6. Merck and Co. (MRK:NYSE, $76.44 bn)
7. AstraZeneca (AZN:NYSE, $73.36 bn)
8. Abbott Labs (ABT:NYSE, $67.70 bn)
9. Wyeth (WYE:NYSE, $67.17 bn)
10. Eli Lilly and Co. (LLY:NYSE, $63.53 bn)
(Link)
No comments:
Post a Comment